Buy Crypto
Markets
Spot
FuturesBTC
Earn
Event Center
Rewards Hub
More
100%+ PoR
CoreWeave (NASDAQ: CRWV) closed its latest session at $53.13, down $3.47 (−6.13%). That one number hides the bigger picture: the stock has lost $23.20, or 30.39%, over the past month and is 35.91% lowCoreWeave (NASDAQ: CRWV) closed its latest session at $53.13, down $3.47 (−6.13%). That one number hides the bigger picture: the stock has lost $23.20, or 30.39%, over the past month and is 35.91% low

CRWV Stock Analysis: Down 30% in a Month, Post-Earnings Pop Fading, Base or Breakdown?

CoreWeave (NASDAQ: CRWV) closed its latest session at $53.13, down $3.47 (−6.13%). That one number hides the bigger picture: the stock has lost $23.20, or 30.39%, over the past month and is 35.91% lower year to date. Five sessions ago it traded near $46.37, so it is still $6.76 (+14.57%) above that level, but roughly two-thirds of the post-earnings pop that carried it above $60 on Nov 11 has already been given back.
The move comes right after the Nov 10 earnings marker on the chart, and with analysts still rating the stock a Buy while the lowest 12-month target ($39.00) now sits below the current price. This technical analysis walks through what the chart, the moving averages, the oscillators and the pivot levels say, and where the line between a base and a breakdown sits.

Key Highlights

  • Price: $53.13, −6.13% on the day, +14.57% over five days, −30.39% over the past month, −35.91% year to date.
  • Trend: TradingView's moving-average gauge reads Strong Sell (13 Sell, 1 Neutral, 1 Buy). The overall summary reads Sell (14 Sell, 9 Neutral, 3 Buy).
  • Oscillators: Neutral (1 Sell, 8 Neutral, 2 Buy). RSI(14) is 43.11 and Stochastic %K is 68.26, so the stock is not oversold after the bounce.
  • Earnings reaction: a gap-up into Nov 11 (high near $62), a gap-down on Nov 12, then a rejection on Nov 13 that closed near the lows of the day's range.
  • Overhead resistance: about $56.60–$58.70, then a cluster at roughly $61–$64, then the 50-day average near $68–$73.
  • Downside markers: about $50–$51, the Nov 13 low near $49.2, then roughly $46–$47, $43.33 and the Nov 5 low near $41.
  • Analysts: consensus Buy (30 Strong Buy, 3 Buy, 11 Hold, 1 Sell, 2 Strong Sell), average 12-month target $114.13, but the lowest target ($39.00) is below the current price.
  • Fundamentals: net loss of about $1.17B on $5.13B of fiscal-year revenue, trailing EPS of −$4.71, and a 1-year beta of 3.64.

1. The Price Action: A Falling Staircase With a Fresh Floor

The one-month and year-to-date charts both show lower highs. A month ago CRWV traded near $76 (the $23.20 loss implies roughly $76.33). From there it slid toward $60, bounced to the mid-$60s in late October, and then broke down again into the Nov 5 low near $41, a drop of more than 35% from the month's starting point.
The year-to-date picture adds context. CRWV began the year near $82.90 (implied by the −$29.77 YTD change), climbed to a spring peak in the area of $120 on a closing basis (wicks reach higher), and has since lost most of that advance. The Nov 5 low near $41 is the lowest point on the year-to-date chart, and the stock now sits roughly 56% below the spring closing high.
There is one constructive detail. The Nov 13 low near $49.2 is well above the Nov 5 low near $41, so the short-term sequence of lows has turned up. The sequence of highs has not: the Nov 11 peak near $62 stands below the late-October bounce and far below the $80 area from mid-October. Higher lows with lower highs is a coiling pattern, not a trend change.

2. The Nov 10–13 Sequence: Earnings Gap, Spike, Gap Down, Rejection

The daily chart tells the earnings story in four candles (levels are read visually from the chart, so treat them as approximate).
  • Nov 10: a small green candle near $48–$49 carries the earnings marker.
  • Nov 11: CRWV gapped up from about $48.7 to roughly $56, ran to a high near $62 and closed near $60.8, a gain of about 25% on the day. It also carries the heaviest volume bar on the chart, which looks like roughly 165M shares.
  • Nov 12: the stock gapped back down to about $51 (low near $50.2), recovered to a high near $58.6 and closed at $56.60, the prior close implied by Nov 13's −$3.47.
  • Nov 13: it opened near $56, sold off to a low near $49.2 and closed at $53.13, a red candle with a long lower shadow. Volume was 80.15M shares, above the 30-day average of 66.44M.
CRWV daily candlestick chart with volume, TradingView (Nov 13 close: $53.13)
The takeaway: the earnings gap-up could not hold, and the first real resistance near $56.60 (the Nov 12 close) rejected price again on Nov 13. The $49–$51 area has now been tested twice in two sessions and defended both times. Bulls have a floor to point to; they do not yet have a recovery.
The Nov 11 and Nov 12 volume bars are the heaviest on the chart, so the $50–$62 range is where the most shares changed hands. Both edges of that range now matter.

3. Moving Averages: Almost Everything Above Price

The moving-average gauge reads Strong Sell, with 13 Sell, 1 Neutral and 1 Buy. Every average from the 20-day up to the 200-day sits above the current price:
  • 10-day: EMA $53.60 (Sell), SMA $51.06 (Buy)
  • 20-day: EMA $57.20, SMA $54.99
  • 30-day: EMA $61.40, SMA $62.86
  • 50-day: EMA $67.92, SMA $72.60
  • 100-day: EMA $77.18, SMA $79.20
  • 200-day: EMA $85.65, SMA $88.99 (about 61–68% above price)
  • Volume-weighted MA (20): $55.58 (Sell); Hull MA (9): $58.02 (Sell); Ichimoku base line: $62.02 (Neutral)
Only one reading flashes a Buy: the 10-day SMA at $51.06, about 3.9% below the current price. That is the fastest-reacting simple average on the list, and it is saying that the five-day bounce lifted price back above its short-term mean, not that the trend has turned. The 10-day EMA ($53.60) is still just above price and reads Sell.
Two structural points stand out. First, a death cross has already printed: the 50-day SMA ($72.60) is $16.39 below the 200-day SMA ($88.99), and the exponential pair is $17.73 apart. Second, three readings are packed between $61.40 and $62.86 (the 30-day EMA, the Ichimoku base line and the 30-day SMA), which sits right under the Nov 11 high near $62 and forms the first thick ceiling for any sustained recovery.

4. Oscillators: Neutral, Not Oversold

The oscillator gauge reads Neutral (1 Sell, 8 Neutral, 2 Buy). The individual readings:
  • Relative Strength Index (14): 43.11 (Neutral), mid-range after the bounce.
  • Stochastic %K (14, 3, 3): 68.26 (Neutral).
  • Stochastic RSI Fast: 83.95 (Neutral), the most stretched reading, but on the upside.
  • Commodity Channel Index (20): −28.23 (Neutral).
  • Williams %R (14): −47.29 (Neutral).
  • Momentum (10): −1.74 (Buy).
  • MACD Level (12, 26): −5.70 (Buy).
  • Bull Bear Power: −3.18 (Sell), the lone bearish oscillator.
  • ADX (14): 36.56 (Neutral).
  • Awesome Oscillator: −13.43 and Ultimate Oscillator (7, 14, 28): 59.96 (both Neutral).
This is a different setup from a washed-out chart. Nothing here is oversold; the two Buy signals come from momentum and MACD flattening out after the sell-off, even though the MACD level is still negative. An ADX of 36.56 describes a strong trend, and with price down 30% in a month, that trend is lower. Stochastic RSI at 83.95 warns that the short-term bounce is already extended, which fits the rejection near $56.60. The oscillators give the bulls no cushion: a move lower from here would start from neutral readings, not from an oversold base.

5. Pivots and Key Levels: Mapping the Battleground

The Classic, Fibonacci and Camarilla central pivot sits at $66.44 and the Woodie pivot at $63.91, both well above the current price. Support levels from the wider pivot grid ($39.67 to $51.02) are the closest to the market, while Camarilla resistance sits tight around price. Overhead levels, nearest first:
  • $56.60–$58.70: the Nov 12 close ($56.60), the 20-day EMA ($57.20), the Hull MA ($58.02) and Camarilla R1 ($58.72). The 20-day SMA ($54.99) and the 20-day VWMA ($55.58) sit just below this band.
  • $61–$64: the 30-day EMA ($61.40), Ichimoku base line ($62.02), Camarilla R2 ($62.56), 30-day SMA ($62.86), Woodie pivot ($63.91) and the Nov 11 high near $62.
  • $66–$68: Camarilla R3 ($66.41), the Classic/Fibonacci/Camarilla pivot ($66.44) and the 50-day EMA ($67.92).
  • $72–$83: the 50-day SMA ($72.60), Woodie R1 ($76.57), the 100-day averages ($77.18 and $79.20), Classic R1 ($81.64) and Fibonacci R1 ($82.47).
Below the market, nearest first:
  • $50–$51: the 10-day SMA ($51.06), Camarilla S1 ($51.02) and Fibonacci S1 ($50.41), plus the Nov 12 low near $50.2.
  • About $49.2: the Nov 13 intraday low.
  • $47.18: Camarilla S2, about 11.2% below the current price.
  • $43.33: Camarilla S3, about 18.4% below.
  • About $41: the Nov 5 low, with Fibonacci S2 ($40.50), Classic S1 ($39.67) and the lowest analyst target ($39.00) all within a couple of dollars below it.
  • $34.61: Woodie S1, about 34.9% below the current price.

6. Analyst Targets and Fundamentals

The analyst picture and the technical picture point in different directions. According to TradingView, 47 analysts have issued ratings in the past three months: 30 Strong Buy, 3 Buy, 11 Hold, 1 Sell and 2 Strong Sell, for a consensus of Buy. Among 39 analysts offering one-year price targets, the average is $114.13 (+114.81% from current), the minimum is $39.00 (−26.60%) and the maximum is $278.00 (+423.24%).
Unlike a stock whose lowest target sits above the market, here the low end is already below the current price, and the gap between low and high is more than sevenfold. That spread shows how divided views are on a company that is growing fast but still losing money. Treat the targets as sentiment context, not as a level the chart is obliged to reach.
The fundamentals explain both sides of the debate:
  • Growth: the income-statement chart shows revenue rising every quarter from Q3 '25 to Q3 '26. Q1 '26 revenue was $2.08B, and the Q3 '26 bar reads roughly $3.6–$3.7B (read visually from the chart).
  • Losses: net income is negative in every quarter shown. Q1 '26 net income was −$740M (a −35.61% net margin); the Q3 '26 margin improves to roughly −20% by eye. Fiscal-year net income is −$1.17B on $5.13B of revenue, and trailing EPS is −$4.71.
  • Size and risk: market capitalization is $29.16B, the share float is 349.31M and the 1-year beta is 3.64, which is why daily moves of 6% to 25% are normal for this stock.
  • Dividend: CRWV has never paid a dividend and has no current plans to.
  • News flow: TradingView's overview cites a deal to supply compute for Harell Data's secure AI training on CoreWeave Cloud, covering training, fine-tuning and inference, billed per run with revenue split per job.
The earnings catalyst has already passed: the chart marks it on Nov 10, and the Q3 '26 bar is the latest in the income statement. The next report date is not shown in the screenshots, so the near-term drivers are now the post-earnings range and the broader AI-infrastructure sentiment.

7. Scenarios to Watch

  • Bullish: price holds the $49–$51 area, reclaims $56.60 and then closes above the $58–$59 band (Hull MA and Camarilla R1). The next hurdle is the $61–$64 cluster, which also contains the Nov 11 high near $62. Until then, any rally is a bounce inside a downtrend.
  • Neutral: price chops between roughly $49 and $57 as the market digests the earnings reaction.
  • Bearish: a close below $49.2 reopens the path to $47.18 and $43.33. A decisive break there would put the Nov 5 low near $41 back in play, and below it the $39–$40 area where Classic S1, Fibonacci S2 and the lowest analyst target cluster.

Conclusion

CRWV sits below almost every major moving average, has already printed a death cross, and is 30.39% lower than a month ago. Against that, the Nov 5 low near $41 has held, the Nov 12 and Nov 13 lows near $50 and $49 form a higher floor, and the analyst community is overwhelmingly positive on a company whose revenue keeps climbing.
The oscillators offer neither an oversold bounce signal nor a warning of an immediate collapse. The market is split between a base forming above $49 and a downtrend that has not yet produced a higher high. The levels that matter are clear: $49–$51 below, $56.60–$58.70 and $61–$64 above. How price behaves around them in the coming sessions will show which story is winning.

Frequently Asked Questions

Is CRWV stock a buy right now based on technicals?

TradingView's technical summary reads Sell (14 Sell, 9 Neutral, 3 Buy), and the moving averages read Strong Sell. Analysts, by contrast, rate the stock a Buy. This article is a technical review, not a recommendation.

What are the key support and resistance levels for CRWV?

On the downside: about $50–$51, about $49.2, $47.18, $43.33 and about $41. On the upside: $56.60–$58.70, $61–$64, $66–$68 and $72–$83.

Is CRWV oversold?

No. RSI(14) is 43.11, Stochastic %K is 68.26 and Stochastic RSI is 83.95, and the oscillator gauge is Neutral. The stock fell sharply over the month, but the five-day bounce has pulled these readings out of oversold territory.

When does CoreWeave report earnings?

The chart marks the latest report on Nov 10, and the income statement already includes Q3 '26. The next report date is not shown in the TradingView screenshots, so check the company's investor relations page for the schedule.

What is the analyst price target for CRWV?

The average one-year target is $114.13, with a low of $39.00 and a high of $278.00, based on 39 analysts. The rating consensus is Buy across 47 analysts.

Does CRWV pay a dividend?

No. TradingView states that CRWV has never paid dividends and has no current plans to do so.
 

Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice or a recommendation to buy, sell or hold any security. All figures are drawn from TradingView screenshots as of the Nov 13 close; chart levels and quarterly figures marked as approximate are read visually from the charts. Technical indicators are not guarantees of future performance. Always do your own research and consider your personal circumstances before making any trading decision.

Market Opportunity
4 Logo
4 Price(4)
$0.00853
$0.00853$0.00853
USD

The articles shared on this page are sourced from public platforms and are provided for reference only. They do not represent the position or views of MEXC. All rights belong to MEXC Editorial Team. If you believe any content infringes upon the rights of a third party, please contact service@support.mexc.com for prompt removal. MEXC does not guarantee the accuracy, completeness, or timeliness of any content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be interpreted as a recommendation or endorsement by MEXC. For expert insights and in-depth analysis, visit MEXC Learn.